Aims To evaluate CK19, RET, galectin-3 and HBME-1 expression in papillary thyroid
carcinoma (PTC) and to evaluate their diagnostic significance. Methods 155 PTC specimens …

Background: Fine needle aspiration biopsy (FNAB) is a common and excellent procedure for
the evaluation of thyroid lesions that require surgical resection. At times, the FNAB diagnosis …

Background To evaluate the expression and differential diagnostic significance of CK19, TG,
Ki67 and galectin-3 in papillary thyroid carcinoma (PTC)(metastatic and non metastatic) …

Aim of the study is to evaluate the expression of CK19, galectin-3, HBME-1, CD56, claudin-1
and neutrophil gelatinase-associated lipocalin (NGAL) in papillary thyroid carcinoma (PTC) …

Background Several immunohistochemical markers have been used to aid in the diagnosis
of follicular-derived lesions of the thyroid (FDLT). In this study we analyze the diagnostic …

Objectives To investigate the ability of cytokeratin (CK)-19, galectin-3, human bone marrow
endothelial cell (HBME)-1 and tyrosine kinase-type cell surface receptor HER2 (HER-2/neu) …

Objectives: To evaluate the expression and significance of CK19, TPO, and HBME-1 in the
differential diagnosis of papillary thyroid carcinoma (PTC) and nonmalignant nodules …

Aims: The histological diagnosis is critical for the postsurgical management and follow‐up of
thyroid malignancies. The differential diagnosis between papillary carcinoma and …

Respectively 73.8%, 83.3%, 69% and 50% of all papillary carcinomas were positive with
HBME-1, CK19, galectin-3 and TROP-2. CK19 was positive respectively by 100%, 43.5 …

The study aimed at evaluating the diagnostic accuracy of cytokeratin 19 (CK-19), Galectin-3
and hector battifora mesothelial antigen-1 (HBME-1) for papillary thyroid carcinoma (PTC) …